In the pharmaceutical industry, IT organizations face a critical decision when managing unified clinical development platforms: whether to adopt a product-centric BizDevOps model or a centralized Center of Excellence (CoE) model. This choice is pivotal as pharmaceutical companies strive to bring
In a significant move, Compass Pathways has announced its decision to lay off 30% of its workforce, streamline its research efforts, and explore selling its digital technologies. This decision comes in response to delays in the development of its lead drug, a synthetic form of psilocybin aimed at
Recent developments in the pharmaceutical industry underscore the volatile nature of advancements and market dynamics affecting prominent companies. The latest updates reveal a mix of struggles and achievements that highlight how pharmaceutical giants are navigating the complexities of drug
LakeShore Biopharma Co., Ltd (NASDAQ: LSB), a prominent biopharmaceutical company, has successfully regained compliance with Nasdaq's minimum bid price requirement after experiencing non-compliance due to a prolonged period of its share price falling below $1.00. As of October 21, 2024, the company
The Food and Drug Administration’s (FDA) Center for Devices and Radiological Health (CDRH) is experiencing a transformative period marked by the recent appointment of Michelle Tarver as its new director. Tarver, a clinical ophthalmologist with extensive experience within the FDA, steps into her
The Global Plasma Protein Therapeutics Market is on a significant growth trajectory, projected to reach approximately USD 40 billion by 2030. This expansion is driven by the indispensable role that plasma protein therapies play in treating a wide array of medical conditions, such as hemophilia,
